Drug:
Reaction: PRODUCT USE ISSUE
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26518320 |
US |
2 | |
Product use issue, Intentional product misuse, |
||||
| 302 | 26518330 |
US |
70 | 2 |
Product use issue, Colitis, Malaise, Fatigue, Product use issue, Headache, Fatigue, |
||||
| 303 | 26518501 |
US |
77 | 2 |
Product use issue, Rash, |
||||
POMALIDOMIDE, |
||||
| 304 | 26518545 |
US |
2 | |
Product use issue, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
| 305 | 26518575 |
US |
39 | 2 |
Product use issue, Inappropriate schedule of product administration, |
||||
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE, |
||||
| 306 | 26518577 |
US |
2 | |
Product use issue, |
||||
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE, |
||||
| 307 | 26518598 |
EU |
13 | 2 |
Intentional overdose, Abdominal pain, Nausea, Vomiting, Headache, Product use issue, Suicide attempt, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 308 | 26518984 |
US |
70 | 2 |
Pain, Product use issue, |
||||
PEMBROLIZUMAB, LENVATINIB, LINACLOTIDE, LORATADINE, LORATADINE ORAL, NALOXONE, OXYCODONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PROCHLORPERAZINE MALEATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AMLODIPINE BESYLATE, |
||||
| 309 | 26519124 |
US |
6 | 1 |
Cough, Extra dose administered, Product storage error, Product use issue, Product complaint, |
||||
FLUTICASONE FUROATE, FLUTICASONE FUROATE, FLUTICASONE FUROATE, |
||||
| 310 | 26519332 |
US |
2 | |
Therapeutic response unexpected, Product use in unapproved indication, Product use issue, Intentional product misuse, |
||||
| 311 | 26519665 |
US |
67 | 2 |
Respiratory failure, Aspiration, Enterocolitis, Product use issue, |
||||
OLAPARIB, PEMBROLIZUMAB, |
||||
| 312 | 26519729 |
EU |
12 | 2 |
Serotonin syndrome, Neuroleptic malignant syndrome, Drug interaction, Product use issue, |
||||
HALOPERIDOL DECANOATE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 313 | 26519733 |
|||
Product use issue, |
||||
CERTOLIZUMAB PEGOL, ALBUTEROL SULFATE, BACLOFEN, ETONOGESTREL AND ETHINYL ESTRADIOL, PHENTERMINE HYDROCHLORIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
| 314 | 26519805 |
US |
1 | |
Myocardial infarction, Brain neoplasm, Product use issue, |
||||
DAPAGLIFLOZIN, |
||||
| 315 | 26519858 |
US |
69 | 2 |
Hepatic function abnormal, Product use issue, |
||||
| 316 | 26520113 |
US |
||
Gastrointestinal infection, Product use issue, |
||||
C1 ESTERASE INHIBITOR RECOMBINANT, EPINEPHRINE, ADRENALINUM, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, VORTIOXETINE, KETOTIFEN FUMARATE, FEXOFENADINE HYDROCHLORIDE, ISOTRETINOIN, QUERCETIN, QUERCETIN,, BUPRENORPHINE HYDROCHLORIDE, ZALEPLON, OMALIZUMAB, |
||||
| 317 | 26520297 |
CN |
86 | 2 |
Epilepsy, Neutrophil percentage abnormal, Carotid arteriosclerosis, Platelet count abnormal, C-reactive protein abnormal, Cerebral infarction, Red blood cell count abnormal, Haemoglobin abnormal, White blood cell disorder, Cerebral atrophy, Fibrin D dimer increased, Blood potassium abnormal, Blood sodium abnormal, Blood magnesium abnormal, Blood phosphorus abnormal, Alanine aminotransferase abnormal, Aspartate aminotransferase abnormal, Protein total abnormal, Blood albumin abnormal, Blood urea abnormal, Blood creatine abnormal, Brain natriuretic peptide abnormal, PCO2 abnormal, PO2 abnormal, Product preparation issue, Product use issue, |
||||
ERTAPENEM, ERTAPENEM SODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 318 | 26520325 |
13 | 2 | |
Venous thrombosis, Product use issue, Product prescribing issue, Product administration error, Drug chemical incompatibility, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
| 319 | 26520862 |
CA |
43 | 2 |
Urticaria, Ulcer haemorrhage, Pulmonary fibrosis, Peripheral swelling, Pneumonia, Pain in extremity, Migraine, Gait disturbance, Treatment failure, Dyspepsia, Contusion, Contraindicated product administered, Drug ineffective, Drug intolerance, Intentional product use issue, Off label use, Prescribed overdose, Prescribed underdose, Product use in unapproved indication, Product use issue, Therapeutic product effect decreased, Therapeutic response decreased, Therapy non-responder, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CALCIUM CARBONATE, ANTACID, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, CALCIUM GLUCONATE, USTEKINUMAB, USTEKINUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ERGOCALCIFEROL, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, VITAMIN C, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PHENYLEPHRINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM, NAPROXEN, NAPROXEN SODIUM, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SECUKINUMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, CERTOLIZUMAB PEGOL, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LORAZEPAM, CAFFEINE, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, LORAZEPAM, MAGNESIUM, PANTOPRAZOLE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE, RAMIPRIL, RISEDRONATE SODIUM, RISEDRONATE SODIUM, SULFASALAZINE, FISH OIL, TOFACITINIB, |
||||
| 320 | 26521059 |
2 | ||
Disease progression, Diarrhoea, Product use issue, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, PERTUZUMAB, |
||||
| 321 | 26512549 |
US |
||
No adverse event, Product use issue, Product prescribing issue, |
||||
VORTIOXETINE, |
||||
| 322 | 26512716 |
EU |
14 | 1 |
Immunisation, Product use issue, |
||||
INFLIXIMAB, |
||||
| 323 | 26512788 |
US |
61 | 2 |
Product use issue, Product dose omission issue, Product availability issue, Product dispensing issue, |
||||
LISDEXAMFETAMINE, |
||||
| 324 | 26512815 |
US |
2 | |
Fatigue, Dysphonia, Nasal congestion, Pain, Eyelid ptosis, Muscle spasms, Viral infection, Influenza, Neck pain, Back pain, Oropharyngeal pain, Product use issue, |
||||
RAVULIZUMAB, |
||||
| 325 | 26512841 |
US |
72 | 1 |
Death, Product use issue, |
||||
PERFLUOROHEXYLOCTANE, PERFLUOROHEXYLOCTANE, |
||||
| 326 | 26512861 |
US |
70 | 2 |
Neoplasm malignant, Product use issue, |
||||
VORTIOXETINE, |
||||
| 327 | 26512987 |
US |
65 | 2 |
Product use issue, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 328 | 26513112 |
US |
11 | 1 |
Loss of personal independence in daily activities, Dizziness, Drug ineffective, Therapeutic response decreased, Product substitution issue, Product use issue, Product dose omission issue, |
||||
LISDEXAMFETAMINE, |
||||
| 329 | 26513139 |
EU |
15 | 1 |
Suicide attempt, Intentional overdose, Product use issue, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 330 | 26513206 |
US |
87 | 2 |
Cardiac operation, Back pain, Product use issue, |
||||
VIBEGRON, |
||||
| 331 | 26513241 |
US |
1 | |
Product use issue, |
||||
| 332 | 26513260 |
US |
1 | |
Diarrhoea, Product use issue, Treatment noncompliance, |
||||
| 333 | 26513271 |
US |
1 | |
Product use issue, |
||||
| 334 | 26513334 |
MY |
41 | |
Renal impairment, Proteinuria, Product use issue, Therapy partial responder, |
||||
BEVACIZUMAB, BEVACIZUMAB, ERLOTINIB HYDROCHLORIDE, ERLOTINIB, ERLOTINIB HYDROCHLORIDE, ERLOTINIB, QUINAPRIL, QUINAPRIL HYDROCHLORIDE, |
||||
| 335 | 26513341 |
US |
1 | |
Product use issue, |
||||
| 336 | 26513375 |
US |
67 | 2 |
Respiratory failure, Aspiration, Enterocolitis, Product use issue, |
||||
PEMBROLIZUMAB, OLAPARIB, |
||||
| 337 | 26513406 |
US |
1 | |
Diarrhoea, Wrong technique in product usage process, Product use issue, |
||||
SUCROFERRIC OXYHYDROXIDE, CALCIUM ACETATE, CALCIUM ACETATE CAPSULES 667 MG, ISOSORBIDE MONONITRATE, FAMOTIDINE, CARVEDILOL, MECLIZINE HCL 12.5 MG, MECLIZINE HCL 25 MG, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, |
||||
| 338 | 26513435 |
US |
1 | |
Product use issue, |
||||
| 339 | 26513462 |
US |
1 | |
Product use issue, Blood phosphorus increased, |
||||
| 340 | 26513473 |
US |
88 | 2 |
Diarrhoea, Product use issue, |
||||
SUCROFERRIC OXYHYDROXIDE, SUCROFERRIC OXYHYDROXIDE, |
||||
| 341 | 26513475 |
US |
2 | |
Therapy change, Product use issue, |
||||
CALCIUM ACETATE, CALCIUM ACETATE CAPSULES 667 MG, |
||||
| 342 | 26513512 |
US |
2 | |
Product distribution issue, Product use issue, |
||||
| 343 | 26513652 |
US |
1 | |
Diarrhoea, Product use issue, Therapy interrupted, |
||||
FERRIC CITRATE, CALCIUM CARBONATE, |
||||
| 344 | 26513657 |
AR |
59 | 2 |
Pneumothorax, Tumour perforation, Muscle spasms, Pain, Product supply issue, Product use issue, |
||||
FULVESTRANT, RIBOCICLIB, |
||||
| 345 | 26513664 |
US |
2 | |
Headache, Product use issue, Overdose, |
||||
TREPROSTINIL, TREPROSTINIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, LEVOTHYROXINE SODIUM, FUROSEMIDE, ATORVASTATIN CALCIUM, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, GABAPENTIN, SOTATERCEPT-CSRK, PREDNISONE, CINACALCET HYDROCHLORIDE, OXYGEN, 0XYGEN, DIPHENHYDRAMINE HYDROCHLORIDE, AMBRISENTAN, SILDENAFIL CITRATE, SILDENAFIL, |
||||
| 346 | 26513831 |
US |
1 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 347 | 26514001 |
US |
40 | |
Product use issue, No adverse event, |
||||
TOLVAPTAN, TOLVAPTAN, |
||||
| 348 | 26514108 |
US |
66 | 2 |
Hospitalisation, Product use issue, |
||||
RIFAXIMIN, |
||||
| 349 | 26514388 |
SA |
16 | 1 |
Deep vein thrombosis, Vomiting, Product use issue, Product use issue, Prescription drug used without a prescription, Product use in unapproved indication, |
||||
ORAL SEMAGLUTIDE, |
||||
| 350 | 26514675 |
GB |
2 | |
Pregnancy with implant contraceptive, Unintended pregnancy, Abortion induced, Complication associated with device, Product use issue, |
||||
ETONOGESTREL, |
||||
| 351 | 26514825 |
EU |
15 | 2 |
Vomiting, Intentional overdose, Product use issue, Suicide attempt, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 352 | 26515596 |
82 | 1 | |
Drug dependence, Product use issue, Product packaging difficult to open, |
||||
| 353 | 26515617 |
CA |
43 | 2 |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthma, Blister, Breast cancer stage III, Condition aggravated, Contraindicated product administered, Decreased appetite, Depression, Diarrhoea, Discomfort, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug tolerance decreased, Duodenal ulcer perforation, Maternal exposure during pregnancy, Fatigue, Fibromyalgia, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hypersensitivity, Hepatic enzyme increased, Infusion related reaction, Hypoaesthesia, Joint swelling, Pain, Pemphigus, Pericarditis, Off label use, Product use issue, Rash, Rheumatoid factor positive, Swelling, Synovitis, Systemic lupus erythematosus, Treatment failure, Wound, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 354 | 26515758 |
US |
76 | 2 |
Death, Product use issue, |
||||
DEUTETRABENAZINE, |
||||
| 355 | 26516148 |
|||
Viral infection, Product use issue, |
||||
LENIOLISIB, |
||||
| 356 | 26516219 |
US |
2 | |
Device use issue, Product use issue, Product dose omission issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 357 | 26516568 |
US |
38 | 2 |
Systemic lupus erythematosus, Product use issue, |
||||
VOCLOSPORIN, VOCLOSPORIN, |
||||
| 358 | 26516584 |
US |
71 | 2 |
Product use issue, |
||||
ABATACEPT, |
||||
| 359 | 26516808 |
US |
69 | |
Asthma, Drug ineffective, Product use issue, Device delivery system issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 360 | 26519471 |
71 | 1 | |
Psoriasis, Psoriatic arthropathy, Product use issue, Dactylitis, Musculoskeletal stiffness, Musculoskeletal stiffness, Musculoskeletal stiffness, Sacroiliitis, Product prescribing error, |
||||
SUZETRIGINE, LOSARTAN, ROSUVASTATIN, CLOPIDOGREL, OMEGA-3-ACID ETHYL ESTERS, FINASTERIDE, PANTOPRAZOLE, METHOCARBAMOL, METHOCARBAMOL TABLETS, ERGOCALCIFEROL, LINACLOTIDE, POLYETHYLENE GLYCOL 3350, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 361 | 26507736 |
US |
2 | |
Unevaluable event, Product use issue, |
||||
TESTOSTERONE, TESTOSTERONE, |
||||
| 362 | 26507786 |
CA |
44 | 2 |
Type 2 diabetes mellitus, Obesity, Wound infection, Medication error, Product use in unapproved indication, Lupus vulgaris, Psoriatic arthropathy, X-ray abnormal, Prescribed overdose, Malaise, Peripheral venous disease, Paraesthesia, Muscular weakness, Lung disorder, Muscle spasms, Off label use, Product use issue, Sciatica, Rheumatic fever, Memory impairment, Sleep disorder, Migraine, Swollen joint count increased, Weight decreased, Musculoskeletal pain, Osteoarthritis, Night sweats, |
||||
DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, DICLOFENAC, DICLOFENAC SODIUM, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, ALENDRONATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, INDOMETHACIN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DESOGESTREL AND ETHINYL ESTRADIOL, TOCILIZUMAB, TOCILIZUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FOLIC ACID, VEDOLIZUMAB, ALENDRONATE SODIUM, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, SULFASALAZINE, CERTOLIZUMAB PEGOL, PREDNISONE, LEFLUNOMIDE, GOLIMUMAB, ALENDRONATE SODIUM, APREPITANT, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, PREGABALIN, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, CORTISONE ACETATE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DESOXIMETASONE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ETANERCEPT, APREPITANT, FOSAPREPITANT DIMEGLUMINE, METHOTREXATE SODIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, LANSOPRAZOLE, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, HYDROXYCHLOROQUINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ERGOCALCIFEROL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, LORAZEPAM, |
||||
| 363 | 26508030 |
EU |
13 | 2 |
Nausea, Vomiting, Product use issue, Intentional overdose, Suicide attempt, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 364 | 26508054 |
CA |
72 | 2 |
Discoloured vomit, Fall, Hallucination, auditory, Internal haemorrhage, Respiratory arrest, Tremor, Cardiac failure, Drug ineffective, Underdose, Product use issue, |
||||
OLANZAPINE, QUETIAPINE, BREXPIPRAZOLE, BREXPIPRAZOLE, LORAZEPAM, DABIGATRAN ETEXILATE, ERGOCALCIFEROL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NIACIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, LEVOTHYROXINE SODIUM, |
||||
| 365 | 26508271 |
JP |
90 | 2 |
Embolic stroke, Transient ischaemic attack, Paralysis, Muscular weakness, Product use issue, Off label use, |
||||
DAPRODUSTAT, SACUBITRIL AND VALSARTAN, EDOXABAN TOSYLATE, DONEPEZIL HYDROCHLORIDE, EDOXABAN TOSYLATE, |
||||
| 366 | 26508318 |
US |
2 | |
Product dose omission issue, No adverse event, Product use issue, |
||||
SUVOREXANT, |
||||
| 367 | 26508691 |
US |
2 | |
Product use issue, Intentional product misuse, Product physical consistency issue, |
||||
| 368 | 26508756 |
CA |
44 | 2 |
Prescribed overdose, Contraindicated product administered, Intentional product use issue, Product use issue, Adverse drug reaction, Adverse event, Asthma, Dizziness, Diarrhoea, Confusional state, Condition aggravated, C-reactive protein abnormal, Blister, Bursitis, Blood cholesterol increased, Asthenia, Arthralgia, |
||||
SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREGABALIN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PANTOPRAZOLE, DICLOFENAC SODIUM, OXYCODONE, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, RITUXIMAB, PREDNISONE, TRAMADOL HYDROCHLORIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, APREMILAST, PREGABALIN, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, NEOMYCIN OINTMENT, |
||||
| 369 | 26508873 |
US |
||
Product dose omission issue, Product use issue, Off label use, |
||||
LENALIDOMIDE, |
||||
| 370 | 26508952 |
US |
82 | 1 |
Prostate cancer metastatic, Product use issue, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 371 | 26509116 |
US |
2 | |
Product use issue, Intentional product misuse, |
||||
| 372 | 26509223 |
US |
71 | 2 |
Drug ineffective, Product use issue, Accidental exposure to product, Exposure via skin contact, Product delivery mechanism issue, |
||||
EFINACONAZOLE, EFINACONAZOLE, |
||||
| 373 | 26509266 |
US |
||
Product use issue, |
||||
| 374 | 26509495 |
US |
51 | |
Hospitalisation, Product use issue, |
||||
| 375 | 26509504 |
EU |
15 | 2 |
Suicide attempt, Vomiting, Product use issue, Intentional overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 376 | 26509797 |
US |
2 | |
Product use issue, Product complaint, |
||||
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, |
||||
| 377 | 26509998 |
US |
1 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 378 | 26510113 |
CA |
41 | 2 |
Cataract, Urticaria, Lip swelling, Fatigue, Product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, |
||||
| 379 | 26510357 |
US |
2 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 380 | 26510390 |
EU |
16 | 1 |
Suicide attempt, Abdominal pain, Headache, Product use issue, Intentional overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 381 | 26510438 |
US |
87 | 1 |
Rash, Fall, Fatigue, Anal incontinence, Urinary incontinence, Off label use, Product use issue, |
||||
PACRITINIB, PACRITINIB, |
||||
| 382 | 26510815 |
GB |
57 | 2 |
Illness, Confusional state, Fatigue, Diarrhoea, Abdominal distension, Medication error, Product use issue, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 383 | 26510991 |
US |
2 | |
Product use issue, Injection site bruising, |
||||
TIRZEPATIDE, |
||||
| 384 | 26511031 |
EU |
23 | 2 |
Diarrhoea, Hyperaesthesia, General physical health deterioration, Product use issue, Product use issue, Off label use, |
||||
TRAMETINIB, TRAMETINIB, BINIMETINIB, BINIMETINIB, ENCORAFENIB, ENCORAFENIB, PEMBROLIZUMAB, PEMBROLIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LANSOPRAZOLE, LANSOPRAZOLE, GABAPENTIN, QUETIAPINE, PREDNISONE, PREDNISONE, OXAZEPAM, MORPHINE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 385 | 26511085 |
US |
65 | 1 |
Dementia, Product use issue, |
||||
VORTIOXETINE, |
||||
| 386 | 26511289 |
1 | ||
Cholecystectomy, Product use issue, |
||||
GLECAPREVIR AND PIBRENTASVIR, |
||||
| 387 | 26511403 |
|||
Insurance issue, Product use issue, |
||||
AZELAIC ACID, |
||||
| 388 | 26511453 |
US |
86 | 2 |
Product use issue, Peripheral swelling, White blood cell count decreased, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 389 | 26511475 |
84 | 1 | |
Product use issue, |
||||
POLYETHYLENE GLYCOL 3350, CARBIDOPA AND LEVODOPA, |
||||
| 390 | 26511705 |
US |
75 | 1 |
Product use issue, Dysstasia, Headache, |
||||
| 391 | 26512065 |
US |
2 | |
Pneumonia, Product use issue, |
||||
DAPAGLIFLOZIN, DAPAGLIFLOZIN, |
||||
| 392 | 26514521 |
61 | 1 | |
Product use issue, Dialysis, |
||||
AVACOPAN, |
||||
| 393 | 26515418 |
|||
Product use issue, Metastases to pancreas, Metastases to liver, Product dose omission in error, |
||||
ABIRATERONE ACETATE, ABIRATERONE, |
||||
| 394 | 26515666 |
62 | 2 | |
Product use issue, |
||||
AMOXICILLIN, AMOXICILLIN, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, GUAIFENESIN, BENZONATATE, |
||||
| 395 | 26503299 |
US |
2 | |
Drug delivery system issue, Product dose omission issue, Product use issue, |
||||
TERCONAZOLE, |
||||
| 396 | 26503339 |
US |
37 | |
Product use issue, Product dose omission issue, No adverse event, |
||||
BOSENTAN, |
||||
| 397 | 26503396 |
US |
72 | 2 |
Staphylococcal skin infection, Fatigue, Product use issue, |
||||
DOSTARLIMAB, DOSTARLIMAB, LEVOTHYROXINE SODIUM, DOXAZOSIN, DOXAZOSIN MESYLATE, PROPAFENONE HYDROCHLORIDE, PROPAFENONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 398 | 26503402 |
US |
2 | |
Product use issue, Intentional product misuse, |
||||
| 399 | 26503431 |
US |
57 | 2 |
Product dose omission issue, Product use issue, Therapy interrupted, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 400 | 26503626 |
US |
1 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28